Results 141 to 150 of about 2,446,527 (268)
Application of Peter Chew Rule To Jib Crane (Mechanical Engineering)
Chew P.
europepmc +1 more source
Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga +2 more
wiley +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
MECHANICAL & ELECTRICAL ENGINEERING TECHNOLOGY
<正>创刊于1971年(月刊)《机电工程技术》杂志创刊于1971年,为国际大16开本(210mm×285mm),全彩+黑白印刷,月刊(每月20日出版),国内外公开发行,在制造业影响大、读者面广,由广东省机械研究所、广东省机械技术情报站和广东省机械工程学会联合主办。本刊是经过国家科技部、国家新闻出版总署批准出版的大型综合性机电期刊,专注报道机电工业领域的行业动态、先进技术、市场趋势及供求信息 ...
doaj
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
MechRAG: a multimodal large language model for mechanical engineering. [PDF]
Li S, Corney J.
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

